Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 2Gastrointestinal 2Endocrine 2Thoracic 1Sarcoma 1Other solid neoplasm 1Gynecologic 1CNS 1

Conditions

Small Cell Lung Carcinoma 45Lung Neoplasms 42Carcinoma, Non-Small-Cell Lung 38Colorectal Neoplasms 12Pancreatic Neoplasms 10Breast Neoplasms 6Stomach Neoplasms 5Ovarian Neoplasms 5Neoplasm Metastasis 5Triple Negative Breast Neoplasms 4Neoplasms 4Uterine Cervical Neoplasms 3Sarcoma 3Rectal Neoplasms 3Head and Neck Neoplasms 3Esophageal Neoplasms 3Endometrial Neoplasms 3Colonic Neoplasms 3Carcinoma, Renal Cell 3Carcinoma, Ovarian Epithelial 3Recurrence 2Neuroendocrine Tumors 2Kidney Neoplasms 2Extensive Stage Small Cell Lung Cancer 2Adenocarcinoma, Bronchiolo-Alveolar 2Adenocarcinoma of Lung 2Urinary Bladder Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Prostatic Neoplasms 1

Interventions

zimberelimab 1regorafenib 1PM 01183 1Irinotecan 1Clinical Trials, Phase II as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastro-enteropancreatic neuroendocrine tumor × Irinotecan × Thoracic × Clear all
NCT02611024 2025-07-09

Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors

PharmaMar

Phase 1/2 Completed
316 enrolled
CNSEndocrineGastrointestinalGynecologicNETOther solid neoplasmSarcomaThoracic

Gastro-enteropancreatic neuroendocrine tumor, Carcinoma, Ovarian Epithelial, Glioblastoma, Mesothelioma, Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡